For the year ending 2025-12-31, KNSA made $677,564K in revenue. $59,143K in net income. Net profit margin of 8.73%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Revenue | 677,564 | 423,239 | ||
| Cost of goods sold | 77,673 | 60,910 | ||
| Collaboration expenses | 229,545 | 128,311 | ||
| Research and development | 96,853 | 111,623 | ||
| Selling, general and administrative | 196,272 | 168,011 | ||
| Total operating expenses | 600,343 | 468,855 | ||
| Income (loss) from operations | 77,221 | -45,616 | ||
| Other income, net | 11,647 | 9,464 | ||
| Income (loss) before income taxes | 88,868 | -36,152 | ||
| Benefit (provision) for income taxes | 29,863 | 7,041 | ||
| Net income (loss) | 59,005 | -43,193 | ||
| Unrealized gain (loss) on short-term investments and currency translation adjustments, net of tax | 138 | -169 | ||
| Total other comprehensive income (loss) | 138 | -169 | ||
| Total comprehensive income (loss) | 59,143 | -43,362 | ||
| Basic EPS | 0.8 | -0.6 | ||
| Diluted EPS | 0.75 | -0.6 | ||
| Basic Average Shares | 74,200,924 | 71,424,159 | ||
| Diluted Average Shares | 78,979,030 | 71,424,159 | ||
Kiniksa Pharmaceuticals International, plc (KNSA)
Kiniksa Pharmaceuticals International, plc (KNSA)